Means and methods for treating copper-related diseases
Patent
·
OSTI ID:1823931
The present invention relates to the field of (bio-)medicine, and more particularly to the treatment of copper-related diseases. Novel means and methods for depleting (excess) copper from organs and/or the circulation are provided. Agents with a high copper binding affinity and stabilized forms thereof are provided, as well as a novel treatment regimen. The means and methods of the present invention are particularly useful for treatment of Wilson Disease, but also for treatment of other conditions.
- Research Organization:
- Helmholtzzentrum Munchen (Germany); Univ. of Michigan, Ann Arbor, MI (United States); Iowa State Univ., Ames, IA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- SC0006630
- Assignee:
- Helmholtz Zentrum Munchen--Deutsches Forschungszentrum fur Gesundheit und Umwelt (GMBH) (Neuhergerg, DE); Iowa State University Research Foundation, Inc. (Ames, IA); The Regents of the University of Michigan (Ames, IA)
- Patent Number(s):
- 11,000,568
- Application Number:
- 16/063,220
- OSTI ID:
- 1823931
- Resource Relation:
- Patent File Date: 12/16/2016
- Country of Publication:
- United States
- Language:
- English
Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria
|
patent | April 2007 |
Use of methanobactin
|
patent | May 2014 |
Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria
|
patent-application | September 2004 |
Similar Records
Effects of Copper Chelation on BRAFV600E Positive Colon Carcinoma Cells
Treatment of Wilson's disease with zinc. II. Validation of oral /sup 64/copper with copper balance
Cancer genomics predicts disease relapse and therapeutic response to neoadjuvant chemotherapy of hormone sensitive breast cancers
Journal Article
·
Sun May 12 00:00:00 EDT 2019
· Cancers (Basel)
·
OSTI ID:1823931
+3 more
Treatment of Wilson's disease with zinc. II. Validation of oral /sup 64/copper with copper balance
Journal Article
·
Mon Dec 01 00:00:00 EST 1986
· Am. J. Med. Sci.; (United States)
·
OSTI ID:1823931
+2 more
Cancer genomics predicts disease relapse and therapeutic response to neoadjuvant chemotherapy of hormone sensitive breast cancers
Journal Article
·
Mon May 18 00:00:00 EDT 2020
· Scientific Reports
·
OSTI ID:1823931
+2 more